Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.

BMJ open gastroenterology

Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K.
PMID: 26568840
BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015.

OBJECTIVE: Clostridium difficile is a major cause of nosocomial infectious diarrhoea. Treatment of C. difficile infection (CDI) depends on disease severity. A combination of vancomycin and metronidazole is often recommended in severe cases. The aim of this study was...

Cite
Erikstrup LT, Aarup M, Hagemann-Madsen R, et al. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015;2(1):e000038doi: 10.1136/bmjgast-2015-000038.
Erikstrup, L. T., Aarup, M., Hagemann-Madsen, R., Dagnaes-Hansen, F., Kristensen, B., Olsen, K. E., & Fuursted, K. (2015). Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ open gastroenterology, 2(1), e000038. https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup, Lise Tornvig, et al. "Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination." BMJ open gastroenterology vol. 2,1 (2015): e000038. doi: https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015. PMID: 26568840; PMCID: PMC4641438.
Copy Download .nbib Format: NLM
Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations.

International journal of epidemiology

Unnarsdóttir AB, Lovik A, Fawns-Ritchie C, Ask H, Kõiv K, Hagen K, Didriksen M, Christoffersen LAN, Garðarsson AB, McIntosh A, Kähler AK, Campbell A, Hauksdóttir A, Erikstrup C, Mikkelsen DH, Altschul D, Thordardottir EB, Frans EM, Kvale G, Tómasson G, Kariis HM, Jónsdóttir HL, Rúnarsdóttir H, Magnúsdóttir I, Eid J, Jakobsdóttir J, Nielsen KR, Kaspersen KA, Milani L, Trogstad LS, Yi L, Bruun MT, Sullivan PF, Magnus PM, Shen Q, Nesvåg R, Brandlistuen RE, Mägi R, Ostrowski SR, Løkhammer S, Solem S, Reichborn-Kjennerud T, Hansen TF, Werge T, Aspelund T, Porteous DJ, Fang F, Lehto K, Andreassen OA, Pedersen OBV, Hellard SL, Valdimarsdóttir UA.
PMID: 35020900
Int J Epidemiol. 2021 Nov 20; doi: 10.1093/ije/dyab234. Epub 2021 Nov 20.

No abstract available.

Cite
Unnarsdóttir AB, Lovik A, Fawns-Ritchie C, et al. Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. Int J Epidemiol. 2021;doi: 10.1093/ije/dyab234.
Unnarsdóttir, A. B., Lovik, A., Fawns-Ritchie, C., Ask, H., Kõiv, K., Hagen, K., Didriksen, M., Christoffersen, L. A. N., Garðarsson, A. B., McIntosh, A., Kähler, A. K., Campbell, A., Hauksdóttir, A., Erikstrup, C., Mikkelsen, D. H., Altschul, D., Thordardottir, E. B., Frans, E. M., Kvale, G., Tómasson, G., Kariis, H. M., Jónsdóttir, H. L., Rúnarsdóttir, H., Magnúsdóttir, I., Eid, J., Jakobsdóttir, J., Nielsen, K. R., Kaspersen, K. A., Milani, L., Trogstad, L. S., Yi, L., Bruun, M. T., Sullivan, P. F., Magnus, P. M., Shen, Q., Nesvåg, R., Brandlistuen, R. E., Mägi, R., Ostrowski, S. R., Løkhammer, S., Solem, S., Reichborn-Kjennerud, T., Hansen, T. F., Werge, T., Aspelund, T., Porteous, D. J., Fang, F., Lehto, K., Andreassen, O. A., Pedersen, O. B. V., Hellard, S. L., & Valdimarsdóttir, U. A. (2021). Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. International journal of epidemiology, . https://doi.org/10.1093/ije/dyab234
Unnarsdóttir, Anna Bára, et al. "Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations." International journal of epidemiology vol. (2021). doi: https://doi.org/10.1093/ije/dyab234
Unnarsdóttir AB, Lovik A, Fawns-Ritchie C, Ask H, Kõiv K, Hagen K, Didriksen M, Christoffersen LAN, Garðarsson AB, McIntosh A, Kähler AK, Campbell A, Hauksdóttir A, Erikstrup C, Mikkelsen DH, Altschul D, Thordardottir EB, Frans EM, Kvale G, Tómasson G, Kariis HM, Jónsdóttir HL, Rúnarsdóttir H, Magnúsdóttir I, Eid J, Jakobsdóttir J, Nielsen KR, Kaspersen KA, Milani L, Trogstad LS, Yi L, Bruun MT, Sullivan PF, Magnus PM, Shen Q, Nesvåg R, Brandlistuen RE, Mägi R, Ostrowski SR, Løkhammer S, Solem S, Reichborn-Kjennerud T, Hansen TF, Werge T, Aspelund T, Porteous DJ, Fang F, Lehto K, Andreassen OA, Pedersen OBV, Hellard SL, Valdimarsdóttir UA. Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. Int J Epidemiol. 2021 Nov 20; doi: 10.1093/ije/dyab234. Epub 2021 Nov 20. PMID: 35020900.
Copy Download .nbib Format: NLM
Migraine polygenic risk score associates with efficacy of migraine-specific drugs.

Neurology. Genetics

Kogelman LJA, Esserlind AL, Francke Christensen A, Awasthi S, Ripke S, Ingason A, Davidsson OB, Erikstrup C, Hjalgrim H, Ullum H, Olesen J, Folkmann Hansen T.
PMID: 31872049
Neurol Genet. 2019 Oct 24;5(6):e364. doi: 10.1212/NXG.0000000000000364. eCollection 2019 Dec.

OBJECTIVE: To assess whether the polygenic risk score (PRS) for migraine is associated with acute and/or prophylactic migraine treatment response.METHODS: We interviewed 2,219 unrelated patients at the Danish Headache Center using a semistructured interview to diagnose migraine and assess...

Cite
Kogelman LJA, Esserlind AL, Francke Christensen A, et al. Migraine polygenic risk score associates with efficacy of migraine-specific drugs. Neurol Genet. 2019;5(6):e364doi: 10.1212/NXG.0000000000000364.
Kogelman, L. J. A., Esserlind, A. L., Francke Christensen, A., Awasthi, S., Ripke, S., Ingason, A., Davidsson, O. B., Erikstrup, C., Hjalgrim, H., Ullum, H., Olesen, J., Folkmann Hansen, T. (2019). Migraine polygenic risk score associates with efficacy of migraine-specific drugs. Neurology. Genetics, 5(6), e364. https://doi.org/10.1212/NXG.0000000000000364
Kogelman, Lisette J A, et al. "Migraine polygenic risk score associates with efficacy of migraine-specific drugs." Neurology. Genetics vol. 5,6 (2019): e364. doi: https://doi.org/10.1212/NXG.0000000000000364
Kogelman LJA, Esserlind AL, Francke Christensen A, Awasthi S, Ripke S, Ingason A, Davidsson OB, Erikstrup C, Hjalgrim H, Ullum H, Olesen J, Folkmann Hansen T. Migraine polygenic risk score associates with efficacy of migraine-specific drugs. Neurol Genet. 2019 Oct 24;5(6):e364. doi: 10.1212/NXG.0000000000000364. eCollection 2019 Dec. PMID: 31872049; PMCID: PMC6878840.
Copy Download .nbib Format: NLM
ABO blood types and sepsis mortality.

Annals of intensive care

Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU.
PMID: 33877463
Ann Intensive Care. 2021 Apr 20;11(1):61. doi: 10.1186/s13613-021-00844-2.

BACKGROUND: We aimed to determine if the ABO blood types carry different risks of 30-day mortality, acute kidney injury (AKI), and endothelial damage in critically ill patients with sepsis. This was a retrospective cohort study of three independent cohorts...

Cite
Itenov TS, Sessler DI, Khanna AK, et al. ABO blood types and sepsis mortality. Ann Intensive Care. 2021;11(1):61doi: 10.1186/s13613-021-00844-2.
Itenov, T. S., Sessler, D. I., Khanna, A. K., Ostrowski, S. R., Johansson, P. I., Erikstrup, C., Pedersen, O. B., Rygård, S. L., Holst, L. B., Bestle, M. H., Hein, L., Lindhardt, A., Tousi, H., Andersen, M. H., Mohr, T., Lundgren, J. D., & Jensen, J. U. (2021). ABO blood types and sepsis mortality. Annals of intensive care, 11(1), 61. https://doi.org/10.1186/s13613-021-00844-2
Itenov, Theis S, et al. "ABO blood types and sepsis mortality." Annals of intensive care vol. 11,1 (2021): 61. doi: https://doi.org/10.1186/s13613-021-00844-2
Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU. ABO blood types and sepsis mortality. Ann Intensive Care. 2021 Apr 20;11(1):61. doi: 10.1186/s13613-021-00844-2. PMID: 33877463; PMCID: PMC8056100.
Copy Download .nbib Format: NLM
Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Juul Jensen CA, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, Møgelvang R, Gybel-Brask M, Dessau RB, Sørensen E, Harritshøj L, Folke F, Sten C, Engel Møller ME, Benfield T, Ullum H, Jørgensen CS, Erikstrup C, Ostrowski SR, Nielsen SD, Bundgaard H.
PMID: 34543759
Clin Microbiol Infect. 2021 Sep 17; doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17.

OBJECTIVES: Antibodies to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are a key factor in protecting against coronavirus disease 2019 (COVID-19). We examined longitudinal changes in seroprevalence in healthcare workers (HCWs) in Copenhagen and the protective effect of antibodies against...

Cite
Iversen K, Kristensen JH, Hasselbalch RB, et al. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2021;doi: 10.1016/j.cmi.2021.09.005.
Iversen, K., Kristensen, J. H., Hasselbalch, R. B., Pries-Heje, M., Nielsen, P. B., Knudsen, A. D., Fogh, K., Norsk, J. B., Andersen, O., Fischer, T. K., Juul Jensen, C. A., Torp-Pedersen, C., Rungby, J., Ditlev, S. B., Hageman, I., Møgelvang, R., Gybel-Brask, M., Dessau, R. B., Sørensen, E., Harritshøj, L., Folke, F., Sten, C., Engel Møller, M. E., Benfield, T., Ullum, H., Jørgensen, C. S., Erikstrup, C., Ostrowski, S. R., Nielsen, S. D., & Bundgaard, H. (2021). Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, . https://doi.org/10.1016/j.cmi.2021.09.005
Iversen, Kasper, et al. "Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. (2021). doi: https://doi.org/10.1016/j.cmi.2021.09.005
Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Juul Jensen CA, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, Møgelvang R, Gybel-Brask M, Dessau RB, Sørensen E, Harritshøj L, Folke F, Sten C, Engel Møller ME, Benfield T, Ullum H, Jørgensen CS, Erikstrup C, Ostrowski SR, Nielsen SD, Bundgaard H. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2021 Sep 17; doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17. PMID: 34543759; PMCID: PMC8447554.
Copy Download .nbib Format: NLM
Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark.

The Journal of infectious diseases

Kaspersen KA, Hindhede L, Boldsen JK, Mikkelsen S, Vestergaard LS, Berthelsen AN, Moustsen-Helms IR, Holm DK, Nilsson AC, Sækmose SG, Sørensen E, Harritshøj LH, Aagaard B, Hjalgrim H, Lillevang ST, Jørgensen CS, Krause TG, Ullum H, Pedersen OBV, Ostrowski SR, Erikstrup C.
PMID: 34788834
J Infect Dis. 2021 Nov 12; doi: 10.1093/infdis/jiab566. Epub 2021 Nov 12.

BACKGROUND: Studies presenting the SARS-CoV-2 infection fatality rate (IFR) for healthy individuals are warranted. Here we estimate the IFR by age and comorbidity status using data from a large serosurvey among Danish blood donors and nationwide data on COVID-19...

Cite
Kaspersen KA, Hindhede L, Boldsen JK, et al. Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark. J Infect Dis. 2021;doi: 10.1093/infdis/jiab566.
Kaspersen, K. A., Hindhede, L., Boldsen, J. K., Mikkelsen, S., Vestergaard, L. S., Berthelsen, A. N., Moustsen-Helms, I. R., Holm, D. K., Nilsson, A. C., Sækmose, S. G., Sørensen, E., Harritshøj, L. H., Aagaard, B., Hjalgrim, H., Lillevang, S. T., Jørgensen, C. S., Krause, T. G., Ullum, H., Pedersen, O. B. V., Ostrowski, S. R., & Erikstrup, C. (2021). Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiab566
Kaspersen, Kathrine Agergård, et al. "Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark." The Journal of infectious diseases vol. (2021). doi: https://doi.org/10.1093/infdis/jiab566
Kaspersen KA, Hindhede L, Boldsen JK, Mikkelsen S, Vestergaard LS, Berthelsen AN, Moustsen-Helms IR, Holm DK, Nilsson AC, Sækmose SG, Sørensen E, Harritshøj LH, Aagaard B, Hjalgrim H, Lillevang ST, Jørgensen CS, Krause TG, Ullum H, Pedersen OBV, Ostrowski SR, Erikstrup C. Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark. J Infect Dis. 2021 Nov 12; doi: 10.1093/infdis/jiab566. Epub 2021 Nov 12. PMID: 34788834.
Copy Download .nbib Format: NLM
Hyperhidrosis and the risk of being treated for skin infections.

The Journal of dermatological treatment

Henning MAS, Ibler KS, Ostrowski SR, Erikstrup C, Nielsen KR, Bruun MT, Hjalgrim H, Ullum H, Didriksen M, Dinh KM, Rostgaard K, Pedersen OB, Jemec GB.
PMID: 34152896
J Dermatolog Treat. 2021 Jul 05;1-7. doi: 10.1080/09546634.2021.1944971. Epub 2021 Jul 05.

BACKGROUND: A few studies have described an increased prevalence of skin infections in individuals with hyperhidrosis compared to others. However, it remains uncertain whether hyperhidrosis is an independent risk factor for skin infections.OBJECTIVE: To compare the risk of skin...

Cite
Henning MAS, Ibler KS, Ostrowski SR, et al. Hyperhidrosis and the risk of being treated for skin infections. J Dermatolog Treat. 2021;1-7doi: 10.1080/09546634.2021.1944971.
Henning, M. A. S., Ibler, K. S., Ostrowski, S. R., Erikstrup, C., Nielsen, K. R., Bruun, M. T., Hjalgrim, H., Ullum, H., Didriksen, M., Dinh, K. M., Rostgaard, K., Pedersen, O. B., & Jemec, G. B. (2021). Hyperhidrosis and the risk of being treated for skin infections. The Journal of dermatological treatment, 1-7. https://doi.org/10.1080/09546634.2021.1944971
Henning, Mattias A S, et al. "Hyperhidrosis and the risk of being treated for skin infections." The Journal of dermatological treatment vol. (2021): 1-7. doi: https://doi.org/10.1080/09546634.2021.1944971
Henning MAS, Ibler KS, Ostrowski SR, Erikstrup C, Nielsen KR, Bruun MT, Hjalgrim H, Ullum H, Didriksen M, Dinh KM, Rostgaard K, Pedersen OB, Jemec GB. Hyperhidrosis and the risk of being treated for skin infections. J Dermatolog Treat. 2021 Jul 05;1-7. doi: 10.1080/09546634.2021.1944971. Epub 2021 Jul 05. PMID: 34152896.
Copy Download .nbib Format: NLM
Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.

The Journal of infectious diseases

Kaspersen KA, Hindhede L, Boldsen JK, Mikkelsen S, Vestergaard LS, Berthelsen AN, Moustsen-Helms IR, Holm DK, Nilsson AC, Sækmose SG, Sørensen E, Harritshøj LH, Aagaard B, Hjalgrim H, Lillevang ST, Jørgensen CS, Krause TG, Ullum H, Pedersen OBV, Ostrowski SR, Erikstrup C.
PMID: 34788834
J Infect Dis. 2022 Jan 18;225(2):219-228. doi: 10.1093/infdis/jiab566.

BACKGROUND: Studies presenting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) for healthy individuals are warranted. We estimate IFR by age and comorbidity status using data from a large serosurvey among Danish blood donors and nationwide...

Cite
Kaspersen KA, Hindhede L, Boldsen JK, et al. Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark. J Infect Dis. 2022;225(2):219-228doi: 10.1093/infdis/jiab566.
Kaspersen, K. A., Hindhede, L., Boldsen, J. K., Mikkelsen, S., Vestergaard, L. S., Berthelsen, A. N., Moustsen-Helms, I. R., Holm, D. K., Nilsson, A. C., Sækmose, S. G., Sørensen, E., Harritshøj, L. H., Aagaard, B., Hjalgrim, H., Lillevang, S. T., Jørgensen, C. S., Krause, T. G., Ullum, H., Pedersen, O. B. V., Ostrowski, S. R., & Erikstrup, C. (2022). Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark. The Journal of infectious diseases, 225(2), 219-228. https://doi.org/10.1093/infdis/jiab566
Kaspersen, Kathrine Agergård, et al. "Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark." The Journal of infectious diseases vol. 225,2 (2022): 219-228. doi: https://doi.org/10.1093/infdis/jiab566
Kaspersen KA, Hindhede L, Boldsen JK, Mikkelsen S, Vestergaard LS, Berthelsen AN, Moustsen-Helms IR, Holm DK, Nilsson AC, Sækmose SG, Sørensen E, Harritshøj LH, Aagaard B, Hjalgrim H, Lillevang ST, Jørgensen CS, Krause TG, Ullum H, Pedersen OBV, Ostrowski SR, Erikstrup C. Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark. J Infect Dis. 2022 Jan 18;225(2):219-228. doi: 10.1093/infdis/jiab566. PMID: 34788834; PMCID: PMC8689980.
Copy Download .nbib Format: NLM
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19.

Microbiology spectrum

Fogh K, Strange JE, Scharff BFSS, Eriksen ARR, Hasselbalch RB, Bundgaard H, Nielsen SD, Jørgensen CS, Erikstrup C, Norsk J, Nielsen PB, Kristensen JH, Østergaard L, Ellermann-Eriksen S, Andersen B, Nielsen H, Johansen IS, Wiese L, Simonsen L, Fischer TK, Folke F, Lippert F, Ostrowski SR, Benfield T, Mølbak K, Ethelberg S, Koch A, Sönksen UW, Vangsted AM, Krause TG, Fomsgaard A, Ullum H, Skov R, Iversen K.
PMID: 34908473
Microbiol Spectr. 2021 Dec 22;9(3):e0133021. doi: 10.1128/Spectrum.01330-21. Epub 2021 Dec 15.

"Testing Denmark" is a national, large-scale, epidemiological surveillance study of SARS-CoV-2 in the Danish population. Between September and October 2020, approximately 1.3 million people (age >15 years) were randomly invited to fill in an electronic questionnaire covering COVID-19 exposures...

Cite
Fogh K, Strange JE, Scharff BFSS, et al. Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19. Microbiol Spectr. 2021;9(3):e0133021doi: 10.1128/Spectrum.01330-21.
Fogh, K., Strange, J. E., Scharff, B. F. S. S., Eriksen, A. R. R., Hasselbalch, R. B., Bundgaard, H., Nielsen, S. D., Jørgensen, C. S., Erikstrup, C., Norsk, J., Nielsen, P. B., Kristensen, J. H., Østergaard, L., Ellermann-Eriksen, S., Andersen, B., Nielsen, H., Johansen, I. S., Wiese, L., Simonsen, L., Fischer, T. K., Folke, F., Lippert, F., Ostrowski, S. R., Benfield, T., Mølbak, K., Ethelberg, S., Koch, A., Sönksen, U. W., Vangsted, A. M., Krause, T. G., Fomsgaard, A., Ullum, H., Skov, R., & Iversen, K. (2021). Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19. Microbiology spectrum, 9(3), e0133021. https://doi.org/10.1128/Spectrum.01330-21
Fogh, Kamille, et al. "Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19." Microbiology spectrum vol. 9,3 (2021): e0133021. doi: https://doi.org/10.1128/Spectrum.01330-21
Fogh K, Strange JE, Scharff BFSS, Eriksen ARR, Hasselbalch RB, Bundgaard H, Nielsen SD, Jørgensen CS, Erikstrup C, Norsk J, Nielsen PB, Kristensen JH, Østergaard L, Ellermann-Eriksen S, Andersen B, Nielsen H, Johansen IS, Wiese L, Simonsen L, Fischer TK, Folke F, Lippert F, Ostrowski SR, Benfield T, Mølbak K, Ethelberg S, Koch A, Sönksen UW, Vangsted AM, Krause TG, Fomsgaard A, Ullum H, Skov R, Iversen K. Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19. Microbiol Spectr. 2021 Dec 22;9(3):e0133021. doi: 10.1128/Spectrum.01330-21. Epub 2021 Dec 15. PMID: 34908473; PMCID: PMC8672904.
Copy Download .nbib Format: NLM
No association between plasma hepcidin levels and restless legs syndrome - results from the Danish Blood Donor Study.

Sleep medicine

Dowsett J, Didriksen M, Larsen MH, Burgdorf KS, Thørner LW, Sørensen E, Erikstrup C, Pedersen OB, Ostrowski SR, Ullum H.
PMID: 34736065
Sleep Med. 2021 Dec;88:68-73. doi: 10.1016/j.sleep.2021.10.008. Epub 2021 Oct 15.

BACKGROUND: Restless Legs Syndrome (RLS) is a neurological sensorimotor disorder that occurs in the evening and night, thereby often impacting quality of sleep in sufferers. The aetiology of RLS is not completely understood although iron dysregulation has been suggested...

Cite
Dowsett J, Didriksen M, Larsen MH, et al. No association between plasma hepcidin levels and restless legs syndrome - results from the Danish Blood Donor Study. Sleep Med. 2021;88:68-73doi: 10.1016/j.sleep.2021.10.008.
Dowsett, J., Didriksen, M., Larsen, M. H., Burgdorf, K. S., Thørner, L. W., Sørensen, E., Erikstrup, C., Pedersen, O. B., Ostrowski, S. R., & Ullum, H. (2021). No association between plasma hepcidin levels and restless legs syndrome - results from the Danish Blood Donor Study. Sleep medicine, 8868-73. https://doi.org/10.1016/j.sleep.2021.10.008
Dowsett, Joseph, et al. "No association between plasma hepcidin levels and restless legs syndrome - results from the Danish Blood Donor Study." Sleep medicine vol. 88 (2021): 68-73. doi: https://doi.org/10.1016/j.sleep.2021.10.008
Dowsett J, Didriksen M, Larsen MH, Burgdorf KS, Thørner LW, Sørensen E, Erikstrup C, Pedersen OB, Ostrowski SR, Ullum H. No association between plasma hepcidin levels and restless legs syndrome - results from the Danish Blood Donor Study. Sleep Med. 2021 Dec;88:68-73. doi: 10.1016/j.sleep.2021.10.008. Epub 2021 Oct 15. PMID: 34736065.
Copy Download .nbib Format: NLM
A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy.

Scientific reports

Skuladottir AT, Bjornsdottir G, Thorleifsson G, Walters GB, Nawaz MS, Moore KHS, Olason PI, Thorgeirsson TE, Sigurpalsdottir B, Sveinbjornsson G, Eggertsson HP, Magnusson SH, Oddsson A, Bjornsdottir A, Vikingsson A, Sveinsson OA, Hrafnsdottir MG, Sigurdardottir GR, Halldorsson BV, Hansen TF, Paarup H, Erikstrup C, Nielsen K, Klokker M, Bruun MT, Sorensen E, Banasik K, Burgdorf KS, Pedersen OB, Ullum H, Jonsdottir I, Stefansson H, Stefansson K.
PMID: 33602968
Sci Rep. 2021 Feb 18;11(1):4188. doi: 10.1038/s41598-021-82736-w.

Bell's palsy is the most common cause of unilateral facial paralysis and is defined as an idiopathic and acute inability to control movements of the facial muscles on the affected side. While the pathogenesis remains unknown, previous studies have...

Cite
Skuladottir AT, Bjornsdottir G, Thorleifsson G, et al. A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy. Sci Rep. 2021;11(1):4188doi: 10.1038/s41598-021-82736-w.
Skuladottir, A. T., Bjornsdottir, G., Thorleifsson, G., Walters, G. B., Nawaz, M. S., Moore, K. H. S., Olason, P. I., Thorgeirsson, T. E., Sigurpalsdottir, B., Sveinbjornsson, G., Eggertsson, H. P., Magnusson, S. H., Oddsson, A., Bjornsdottir, A., Vikingsson, A., Sveinsson, O. A., Hrafnsdottir, M. G., Sigurdardottir, G. R., Halldorsson, B. V., Hansen, T. F., Paarup, H., Erikstrup, C., Nielsen, K., Klokker, M., Bruun, M. T., Sorensen, E., Banasik, K., Burgdorf, K. S., Pedersen, O. B., Ullum, H., Jonsdottir, I., Stefansson, H., & Stefansson, K. (2021). A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy. Scientific reports, 11(1), 4188. https://doi.org/10.1038/s41598-021-82736-w
Skuladottir, Astros Th, et al. "A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy." Scientific reports vol. 11,1 (2021): 4188. doi: https://doi.org/10.1038/s41598-021-82736-w
Skuladottir AT, Bjornsdottir G, Thorleifsson G, Walters GB, Nawaz MS, Moore KHS, Olason PI, Thorgeirsson TE, Sigurpalsdottir B, Sveinbjornsson G, Eggertsson HP, Magnusson SH, Oddsson A, Bjornsdottir A, Vikingsson A, Sveinsson OA, Hrafnsdottir MG, Sigurdardottir GR, Halldorsson BV, Hansen TF, Paarup H, Erikstrup C, Nielsen K, Klokker M, Bruun MT, Sorensen E, Banasik K, Burgdorf KS, Pedersen OB, Ullum H, Jonsdottir I, Stefansson H, Stefansson K. A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy. Sci Rep. 2021 Feb 18;11(1):4188. doi: 10.1038/s41598-021-82736-w. PMID: 33602968; PMCID: PMC7893061.
Copy Download .nbib Format: NLM
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

ACR open rheumatology

Ammitzbøll C, Bartels LE, Bøgh Andersen J, Risbøl Vils S, Elbaek Mistegård C, Dahl Johannsen A, From Hermansen ML, Kragh Thomsen M, Erikstrup C, Hauge EM, Troldborg A.
PMID: 34273260
ACR Open Rheumatol. 2021 Sep;3(9):622-628. doi: 10.1002/acr2.11299. Epub 2021 Jul 17.

OBJECTIVE: With a vaccine effectiveness of 95% for preventing coronavirus disease 2019 (COVID-19), Pfizer-BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be approved. However, immunosuppressive therapy was an exclusion criterion in...

Cite
Ammitzbøll C, Bartels LE, Bøgh Andersen J, et al. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. ACR Open Rheumatol. 2021;3(9):622-628doi: 10.1002/acr2.11299.
Ammitzbøll, C., Bartels, L. E., Bøgh Andersen, J., Risbøl Vils, S., Elbaek Mistegård, C., Dahl Johannsen, A., From Hermansen, M. L., Kragh Thomsen, M., Erikstrup, C., Hauge, E. M., & Troldborg, A. (2021). Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. ACR open rheumatology, 3(9), 622-628. https://doi.org/10.1002/acr2.11299
Ammitzbøll, Christian, et al. "Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis." ACR open rheumatology vol. 3,9 (2021): 622-628. doi: https://doi.org/10.1002/acr2.11299
Ammitzbøll C, Bartels LE, Bøgh Andersen J, Risbøl Vils S, Elbaek Mistegård C, Dahl Johannsen A, From Hermansen ML, Kragh Thomsen M, Erikstrup C, Hauge EM, Troldborg A. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. ACR Open Rheumatol. 2021 Sep;3(9):622-628. doi: 10.1002/acr2.11299. Epub 2021 Jul 17. PMID: 34273260; PMCID: PMC8426741.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries